Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Sales: 2020-2023

Historic Return on Sales for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to -155.40%.

  • Benitec Biopharma's Return on Sales was N/A to -155.40% in Q2 2023 from the same period last year, while for Jun 2023 it was -155.40%, marking a year-over-year change of. This contributed to the annual value of -254.85% for FY2023, which is 984.00% down from last year.
  • Benitec Biopharma's Return on Sales amounted to -155.40% in Q2 2023, which was down 13.51% from -136.91% recorded in Q1 2023.
  • In the past 5 years, Benitec Biopharma's Return on Sales ranged from a high of -78.06% in Q3 2020 and a low of -597.24% during Q4 2021.
  • Over the past 3 years, Benitec Biopharma's median Return on Sales value was -223.62% (recorded in 2022), while the average stood at -303.51%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by 37,430bps in 2021, then soared by 39,021bps in 2022.
  • Quarterly analysis of 4 years shows Benitec Biopharma's Return on Sales stood at -222.94% in 2020, then slumped by 37,430bps to -597.24% in 2021, then spiked by 39,021bps to -207.03% in 2022, then surged by 8,671bps to -155.40% in 2023.
  • Its Return on Sales was -155.40% in Q2 2023, compared to -136.91% in Q1 2023 and -207.03% in Q4 2022.